Impact of age on outcomes of Japanese patients with rheumatoid arthritis treated with infliximab: The post marketing surveillance trial.

被引:0
|
作者
Dabbous, O.
Rahman, M. I.
Gilmer, K.
Yano, T.
Nogami, Y.
Arjunji, R.
Thompson, H.
Tang, B.
Takeuchi, T.
Koike, T.
机构
[1] Tanabe Seiyaku Co Ltd, Osaka, Japan
[2] Saitama Med Ctr, Kawagoe, Saitama, Japan
[3] Hokkaido Univ, Sapporo, Hokkaido, Japan
来源
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S421 / S421
页数:1
相关论文
共 50 条
  • [1] Impact of gender on outcome of Japanese patients with rheumatoid arthritis: The post marketing surveillance trial.
    Dabbous, O.
    Rahman, M. I.
    Gilmer, K.
    Yano, T.
    Nogami, Y.
    Arjunji, R.
    Thompson, H.
    Tang, B.
    Takeuchi, T.
    Koike, T.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S55 - S55
  • [2] The influence of comorbid conditions on the safety profile of infliximab treatment in Japanese patients with rheumatoid arthritis: The post-marketing surveillance trial.
    Yano, Toshiro
    Togo, Masanori
    Nogami, Yoshihide
    Takeuchi, Tsutomu
    Koike, Takao
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S426 - S426
  • [3] Tuberculosis in Japanese patients with hheumatoid arthritis treated with infliximab: Findings from the post marketing surveillance trial
    Dabbous, O.
    Gilmer, K.
    Tatsuki, Y.
    Shane, P.
    Togo, M.
    Nogami, Y.
    Tang, B.
    Thompson, H.
    Rahman, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 167 - 167
  • [4] Tuberculosis and serious infusion reactions in Japanese patients with rheumatoid arthritis: Results from the post marketing surveillance trial.
    Dabbous, Omar
    Tatsuki, Yoshihiko
    Rahman, Mirza I.
    Gilmer, Keith
    Arjunji, Ramesh
    Thompson, Heidi
    Togo, Masanori
    Tang, Boxiong
    Suzuki, Toshikazu
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S422 - S422
  • [5] Safety of infliximab therapy in 4,475 Japanese patients with rheumatoid arthritis: Results from post marketing surveillance study
    Takeuchi, T.
    Togo, M.
    Etoh, A.
    Suzuki, T.
    Callegari, P. A.
    Gilmer, K. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 503 - 504
  • [6] Infection Events in Japanese Patients with Rheumatoid Arthritis Treated with Tofacitinib: Interim All-Case Post-Marketing Surveillance
    Tamura, Naoto
    Kuwana, Masataka
    Atsumi, Tatsuya
    Takei, Syuji
    Harigai, Masayoshi
    Fujii, Takao
    Matsuno, Hiroaki
    Mimori, Tsuneyo
    Momohara, Shigeki
    Yamamoto, Kazuhiko
    Takasaki, Yoshinari
    Nomura, Kazuto
    Endo, Yutaka
    Hirose, Tomohiro
    Morishima, Yosuke
    Sugiyama, Naonobu
    Yoshii, Noritoshi
    Takagi, Michiaki
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [7] Malignancy in Japanese Patients with Rheumatoid Arthritis Treated with Tofacitinib: Interim Analysis of All-Case Post-Marketing Surveillance
    Tamura, Naoto
    Kuwana, Masataka
    Atsumi, Tatsuya
    Takei, Syuji
    Harigai, Masayoshi
    Fujii, Takao
    Matsuno, Hiroaki
    Mimori, Tsuneyo
    Momohara, Shigeki
    Yamamoto, Kazuhiko
    Takasaki, Yoshinari
    Nomura, Kazuto
    Endo, Yutaka
    Hirose, Tomohiro
    Morishima, Yosuke
    Sugiyama, Naonobu
    Yoshii, Noritoshi
    Takagi, Michiaki
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [8] Clinical effectiveness, tuberculosis, and serious infusion reactions in Japanese patients with rheumatoid arthritis: Results from the post marketing surveillance trial
    Dabbous, O.
    Tatsuki, Y.
    Arjunji, R.
    Gilmer, K.
    Rahman, M.
    Togo, M.
    Suzuki, T.
    Takeuchi, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 185 - 185
  • [9] Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis
    Takeuchi, T.
    Tatsuki, Y.
    Nogami, Y.
    Ishiguro, N.
    Tanaka, Y.
    Yamanaka, H.
    Kamatani, N.
    Harigai, M.
    Ryu, J.
    Inoue, K.
    Kondo, H.
    Inokuma, S.
    Ochi, T.
    Koike, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (02) : 189 - 194
  • [10] Post-Marketing Surveillance of Tofacitinib in Japanese Patients with Rheumatoid Arthritis: An Interim Report of Safety Data
    Mimori, Tsuneyo
    Harigai, Masayoshi
    Atsumi, Tatsuya
    Kuwana, Masataka
    Takei, Syuji
    Tamura, Naoto
    Fujii, Takao
    Matsuno, Hiroaki
    Momohara, Shigeki
    Yamamoto, Kazuhiko
    Kokubo, Takeshi
    Endo, Yutaka
    Sugiyama, Naonobu
    Hirose, Tomohiro
    Morishima, Yosuke
    Yoshii, Noritoshi
    ARTHRITIS & RHEUMATOLOGY, 2017, 69